logoBC
Yaoundé - 28 March 2024 -
Companies

Cameroon: André Mama Fouda inaugurated a drug production unit in Douala

Cameroon: André Mama Fouda inaugurated a drug production unit in Douala
  • Comments   -   Friday, 19 January 2018 14:28

(Business in Cameroon) - At the end of December 2017, André Mama Fouda, Cameroon’s minister of public health has inaugurated Africure, a company specialized in the production of generic and other essential pharmaceuticals.

Located at Yassa in Douala, the company is the result of the partnership between a private investor (not named so-far) and Indian investors.

The CFA5 billion investment, which allows the mass production of 1 billion drugs, is aimed at reducing drug imports in the country, according to Dr. Prosper Hiag, chairman of the Africure's board of directors.

BRM

mtn-cameroon-sees-record-growth-with-cfa325-7bn-revenue-in-2023-amid-market-challenges
MTN Cameroon reported a robust revenue of CFA325.7 billion for 2023. According to data released on the Johannesburg Stock Exchange in South Africa, this...
cameroon-s-customs-enforces-air-cargo-regulations-threatens-fines-for-non-compliance
Edwin Fongod Nuvaga, the Director-General of Customs in Cameroon, has issued a reminder to airlines about their obligations to comply with standard...
cameroon-s-brewer-sabc-surpasses-decade-s-average-annual-investment-in-2023
Cameroon’s brewing company SABC, a local subsidiary of the Castel Group, claimed a cumulative investment of CFA313 billion over the past decade, as...
cameroon-sabc-s-turnover-falls-by-cfa4bn-yoy-in-2023-despite-increase-in-sales
Cameroonian brewing company SABC announced it has wrapped up 2023 with a turnover of around 729 billion FCFA, slightly down by CFA4 billion compared to...

Mags frontpage


Business in Cameroon n110: April 2022

Covid-19, war in Europe: Some Cameroonian firms will suffer


Albert Zeufack: “Today, the most important market is in Asia”


Investir au Cameroun n120: Avril 2022

Covid-19, guerre en Europe : des entreprises camerounaises vont souffrir


Albert Zeufack: « Le marché le plus important aujourd’hui, c’est l’Asie »